OBI.L LSE
Ondine Biomedical Inc.
1W: -9.3%
1M: -17.0%
3M: -36.7%
YTD: +5.4%
1Y: -40.9%
3Y: -33.9%
£9.75 ($0.13)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$13M
+123.6% ▲
5Y CAGR: +34.5%
Total Liabilities
$6M
+62.9% ▲
5Y CAGR: -27.2%
Shareholders Equity
$7M
+229.8% ▲
Cash & Investments
$10M
+227.6% ▲
5Y CAGR: +99.9%
Total Debt
$168K
-68.9% ▼
5Y CAGR: -64.1%
Net Debt
-$10M
-293.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $626K | $30M | $13M | $3M | $10M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $626K | $30M | $13M | $3M | $10M |
| Net Receivables | $543K | $248K | $182K | $326K | $513K |
| Inventory | $404K | $1M | $1M | $1M | $1M |
| Other Current Assets | $0 | $0 | $147K | $157K | $159K |
| Total Current Assets | $2M | $34M | $15M | $5M | $12M |
| Property, Plant & Equip. | $671K | $601K | $1M | $949K | $597K |
| Goodwill & Intangibles | $171K | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $46K | $35K | $36K | $35K | $37K |
| Total Non-Current Assets | $888K | $636K | $1M | $984K | $634K |
| Total Assets | $3M | $34M | $17M | $6M | $13M |
| — Liabilities — | |||||
| Accounts Payable | $237K | $1M | $388K | $1M | $2M |
| Short-Term Debt | $31M | $497K | $0 | $0 | $0 |
| Deferred Revenue | $1M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $556K | $1M | $2M | $2M |
| Total Current Liabilities | $36M | $4M | $4M | $3M | $6M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $593K | $467K | $481K | $0 | $0 |
| Total Non-Current Liabilities | $678K | $561K | $1M | $159K | $0 |
| Total Liabilities | $36M | $4M | $5M | $4M | $6M |
| — Equity — | |||||
| Common Stock | $120M | $235M | $235M | $240M | $263M |
| Retained Earnings | -$182M | -$233M | -$252M | -$266M | -$285M |
| Accumulated OCI | $0 | $0 | $0 | $0 | $0 |
| Total Stockholders Equity | -$34M | $30M | $12M | $2M | $7M |
| Total Liabilities & Equity | $3M | $34M | $17M | $6M | $13M |
| — Key Metrics — | |||||
| Total Debt | $31M | $739K | $896K | $541K | $168K |
| Net Debt | $31M | -$30M | -$12M | -$2M | -$10M |
| Total Investments | $0 | $0 | $0 | $0 | $0 |